BiotechTube

Dexamethasone

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Nervous System Disorder

Conditions

Nervous System Disorder, Genetic Syndrome

Trial Timeline

Feb 1, 2011 → Dec 1, 2011

NCT ID
NCT01255358

About Dexamethasone

Dexamethasone is a phase 2 stage product being developed by Quince Therapeutics for Nervous System Disorder. The current trial status is completed. This product is registered under clinical trial identifier NCT01255358. Target conditions include Nervous System Disorder, Genetic Syndrome.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT01255358Phase 2Completed
NCT01277289Phase 3Terminated

Competing Products

20 competing products in Nervous System Disorder

See all competitors
ProductCompanyStageHype Score
filgrastim + exatecan mesylateDaiichi SankyoPhase 1
33
Methotrexate + Ibrutinib + TemozolomideSun PharmaceuticalPhase 2
52
alcohol + placebo + alcohol + perampanel + perampanel + alcohol + placebo + alcoholEisaiPhase 1
33
perampanelEisaiPhase 2
52
Tirabrutinib + PlaceboOno PharmaceuticalPhase 2
52
TirabrutinibOno PharmaceuticalPhase 1
33
ONO-4059 + Rituximab + Methotrexate + Procarbazine + VincristineOno PharmaceuticalPhase 1
33
Tirabrutinib + Rituximab + TemozolomideOno PharmaceuticalPhase 3
77
Tirabrutinib + Tirabrutinib + TirabrutinibOno PharmaceuticalPhase 2
52
pemetrexedEli LillyPhase 1
33
HRS-9231 + GadobutrolJiangsu Hengrui MedicinePhase 2
52
AcalabrutinibAstraZenecaPhase 2
52
Durvalumab + AcalabrutinibAstraZenecaPhase 1
33
Avelumab + LenvatinibMerckPhase 1
33
temozolomideMerckPhase 3
77
Ibrutinib + Pembrolizumab + RituximabMerckPhase 1/2
41
TemozolomideMerckPhase 2
52
AEE788 + everolimusNovartisPhase 1/2
41
vatalanibNovartisPhase 2
52
EPO906 (epothilone B)NovartisPhase 1
33

Other Products from Quince Therapeutics

DexamethasonePhase 3
69
EryDex Low dose DSP + EryDex High dose DSP + Pooled PlaceboPhase 3
69
Dexamethasone sodium phosphatePhase 3
69
Dexamethasone sodium phosphatePhase 3
69
Dex 21-P + PlaceboPhase 2
44